Sartorius
Accelerated Early Antibody Discovery Workflows – Label-free, Fluidic-free, Stress-free
Learning Objectives:
• Improve the overall drug discovery process to increase the success rate of preclinical candidates
• Identify elite candidates earlier in screening
• Use a fluidic-free, label-free approach in high-throughput, high-resolution screening for selection of lead candidates in real-time
• Presentation of comparisons across platforms, including traditional ELISA, flow cytometry, surface plasmon resonance (SPR), and in vivo studies
Dr. Colby Sounders
Chief Scientific Officer, Abveris
Register for webinar
Dr. Colby Sounders
Accelerated Early Antibody Discovery Workflows – Label-free, Fluidic-free, Stress-free
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
